CRSP Stock Price & Analysis | CRISPR Therapeutics AG

CRISPR Therapeutics AG (CRSP) Stock AnalysisSector: HealthcareMarket Cap: $5.57BView CRSP financial statements, analyst ratings, Stocklytics Score, price history, and trading signals on Stocklytics.Overview | Financials | Analyst | Prediction | Scores | Dividends